GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) » Definitions » E10

Fujian Cosunter Pharmaceutical Co (SZSE:300436) E10 : ¥-0.12 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Fujian Cosunter Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Fujian Cosunter Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥-0.217. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥-0.12 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Fujian Cosunter Pharmaceutical Co's average E10 Growth Rate was -180.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-06), Fujian Cosunter Pharmaceutical Co's current stock price is ¥32.05. Fujian Cosunter Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 was ¥-0.12. Fujian Cosunter Pharmaceutical Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Fujian Cosunter Pharmaceutical Co was 190.27. The lowest was 99.62. And the median was 120.09.


Fujian Cosunter Pharmaceutical Co E10 Historical Data

The historical data trend for Fujian Cosunter Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fujian Cosunter Pharmaceutical Co E10 Chart

Fujian Cosunter Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -0.01

Fujian Cosunter Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 -0.01 -0.04 -0.07 -0.12

Competitive Comparison of Fujian Cosunter Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Fujian Cosunter Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fujian Cosunter Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fujian Cosunter Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fujian Cosunter Pharmaceutical Co's Shiller PE Ratio falls into.


;
;

Fujian Cosunter Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fujian Cosunter Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.217/115.7848*115.7848
=-0.217

Current CPI (Sep. 2024) = 115.7848.

Fujian Cosunter Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201412 0.164 99.000 0.192
201503 0.492 99.900 0.570
201506 0.179 99.500 0.208
201509 0.214 100.500 0.247
201512 0.119 100.600 0.137
201603 0.201 102.200 0.228
201606 0.090 101.400 0.103
201609 0.132 102.400 0.149
201612 0.047 102.600 0.053
201703 0.144 103.200 0.162
201706 0.048 103.100 0.054
201709 0.015 104.100 0.017
201712 0.033 104.500 0.037
201803 0.085 105.300 0.093
201806 -0.055 104.900 -0.061
201809 0.012 106.600 0.013
201812 0.077 106.500 0.084
201903 0.054 107.700 0.058
201906 0.028 107.700 0.030
201909 0.019 109.800 0.020
201912 -0.024 111.200 -0.025
202003 0.013 112.300 0.013
202006 0.068 110.400 0.071
202009 0.026 111.700 0.027
202012 -0.002 111.500 -0.002
202103 0.013 112.662 0.013
202106 -0.135 111.769 -0.140
202109 -0.018 112.215 -0.019
202112 -0.094 113.108 -0.096
202203 -0.058 114.335 -0.059
202206 -0.107 114.558 -0.108
202209 -0.285 115.339 -0.286
202212 -0.351 115.116 -0.353
202303 -0.398 115.116 -0.400
202306 -0.590 114.558 -0.596
202309 -0.242 115.339 -0.243
202312 -0.959 114.781 -0.967
202403 -0.092 115.227 -0.092
202406 -0.134 114.781 -0.135
202409 -0.217 115.785 -0.217

Add all the adjusted EPS together and divide 10 will get our e10.


Fujian Cosunter Pharmaceutical Co  (SZSE:300436) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Fujian Cosunter Pharmaceutical Co was 190.27. The lowest was 99.62. And the median was 120.09.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Fujian Cosunter Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Fujian Cosunter Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Fujian Cosunter Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Software Park, No. 89, Software Avenue, Block B, Building 10, Zone B, Gulou District, Fujian, Fuzhou, CHN, 350003
Fujian Cosunter Pharmaceutical Co Ltd is a pharmaceutical company engaged in the pharmaceutical production, sales and Research and Development. Its specialized in the field of hepatitis B medicine. Its product includes Fuganding-tenofovir disoproxil fumarate capsule, Enganding-Entecavir Capsules, He Ganding-Lamifuzed tablets and Agandan-adefovir dipivoxil tablets.
Executives
Li Guo Ping Directors, executives
Huang Fu Hu Directors, executives
Li Hong Ming Directors, executives
Guan Jian Hui Executives
Lin Xiao Hui Directors, Directors, and Executives
Ye Li Qing Director
Li Yuan Li Supervisors
Zheng Li Feng Supervisors
Li Guo Dong Directors, executives

Fujian Cosunter Pharmaceutical Co Headlines

No Headlines